Viewing Study NCT00202865



Ignite Creation Date: 2024-05-05 @ 11:59 AM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00202865
Status: COMPLETED
Last Update Posted: 2017-03-24
First Post: 2005-09-16

Brief Title: Evaluation of Low Dose Infliximab in Ankylosing Spondylitis Study P04352
Sponsor: Merck Sharp Dohme LLC
Organization: Merck Sharp Dohme LLC

Study Overview

Official Title: CANaDian Evaluation of Low DosE Infliximab in Ankylosing Spondylitis
Status: COMPLETED
Status Verified Date: 2017-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CANDLE
Brief Summary: This is a randomized double-blind multi-center placebo-controlled study with two parallel treatment groups placebo and infliximab in subjects with ankylosing spondylitis AS to evaluate the efficacy of infliximab 3 mgkg
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2472 None None None